Peer-reviewedCC BY-NC-NDJournal of gastrointestinal oncology16 Oct 2026

Revisiting alpha-fetoprotein thresholds for hepatocellular carcinoma surveillance in the metabolic dysfunction-associated steatotic liver disease era: time for an evidence-based recalibration.

Miguel Suárez^1,2,3
Raquel Gómez-Molina⁴
Ana M Torres^2,3
Jorge Mateo^2,3

4 affiliations

¹Department of Gastroenterology, University Hospital of Cuenca, Cuenca, Castille-La Mancha, Spain.
²Medical Analysis Expert Group, Institute of Technology, Universidad de Castilla-La Mancha, Cuenca, Castille-La Mancha, Spain.
³Medical Analysis Expert Group, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Toledo, Castille-La Mancha, Spain.
⁴Department of Laboratory Medicine, University Hospital of Cuenca, Cuenca, Castille-La Mancha, Spain.

Read full text PDF DOI Cite

Association between alpha-fetoprotein elevation and recurrence in patients who achieved normalized alpha-fetoprotein after curative resection for hepatocellular carcinoma : A retrospective cohort study
Jeong Ah Hwang, Jisun Lee, Kyung Sik Yi +3
Medicine30 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
Case Report: Long term multimodality treatment of canine hepatocellular carcinoma with serial monitoring of serum alpha-fetoprotein.
Tae-Jung Dan, Cheol-Ho Yang, Yeon-Jin Kim +4
Frontiers in veterinary science6 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Early discordance between alpha-fetoprotein response and albumin-bilirubin deterioration refines response assessment in unresectable hepatocellular carcinoma receiving first-line immune-combination therapy: a real-world landmark cohort study
Haitao Wu, Pengju Tang, Jinbo Gong +3
Frontiers in Oncology19 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
Early on-treatment alpha-fetoprotein and des-gamma-carboxy prothrombin responses are associated with outcomes in unresectable hepatocellular carcinoma receiving transarterial chemoembolization, tyrosine kinase inhibitors and programmed cell death protein-1 inhibitors.
Yang Liu, Ya-Pan Guo, Xu-Dong Zhang +3
Journal of gastrointestinal oncology30 Sep 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation
Hang Xu, Jiayang Yi, Wanwan Zhang +2
Frontiers in oncology16 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC

Cite

BibTeX RIS

BibTeX

@article{suarez2026revisiting,
  title = {{Revisiting alpha-fetoprotein thresholds for hepatocellular carcinoma surveillance in the metabolic dysfunction-associated steatotic liver disease era: time for an evidence-based recalibration.}},
  author = {Miguel Suárez and Raquel Gómez-Molina and Ana M Torres and Jorge Mateo},
  journal = {Journal of gastrointestinal oncology},
  year = {2026},
  month = oct,
  doi = {10.21037/jgo-2026-0747},
  url = {https://europepmc.org/article/MED/42996869},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Revisiting alpha-fetoprotein thresholds for hepatocellular carcinoma surveillance in the metabolic dysfunction-associated steatotic liver disease era: time for an evidence-based recalibration.
AU  - Miguel Suárez
AU  - Raquel Gómez-Molina
AU  - Ana M Torres
AU  - Jorge Mateo
PY  - 2026
DA  - 2026/10/16
JO  - Journal of gastrointestinal oncology
DO  - 10.21037/jgo-2026-0747
UR  - https://europepmc.org/article/MED/42996869
SN  - 2078-6891
SN  - 2219-679X
ER  -

Related

Cite